These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23278250)

  • 21. Disposition of flavonoids via enteric recycling: structural effects and lack of correlations between in vitro and in situ metabolic properties.
    Wang SW; Chen J; Jia X; Tam VH; Hu M
    Drug Metab Dispos; 2006 Nov; 34(11):1837-48. PubMed ID: 16882763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of docosahexaenoic acid (DHA) on the intestinal metabolism of midazolam: in vitro and in vivo studies in rats.
    Hirunpanich V; Murakoso K; Sato H
    Int J Pharm; 2008 Mar; 351(1-2):133-43. PubMed ID: 18082981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms.
    Shayeganpour A; El-Kadi AO; Brocks DR
    Drug Metab Dispos; 2006 Jan; 34(1):43-50. PubMed ID: 16204463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P4501A1 mediates the metabolism of 2,3,7,8-tetrachlorodibenzofuran in the rat and human.
    Tai HL; McReynolds JH; Goldstein JA; Eugster HP; Sengstag C; Alworth WL; Olson JR
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):34-42. PubMed ID: 8236259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of animal models for intestinal first-pass metabolism of drug candidates to be metabolized by CYP3A enzymes via in vivo and in vitro oxidation of midazolam and triazolam.
    Kuze J; Mutoh T; Takenaka T; Oda N; Hanioka N; Narimatsu S
    Xenobiotica; 2013 Jul; 43(7):598-606. PubMed ID: 23282066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of rat and human cytochrome p450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides deltamethrin and esfenvalerate.
    Godin SJ; Crow JA; Scollon EJ; Hughes MF; DeVito MJ; Ross MK
    Drug Metab Dispos; 2007 Sep; 35(9):1664-71. PubMed ID: 17576809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and metabolism of 4-O-methylhonokiol in rats.
    Yu HE; Oh SJ; Ryu JK; Kang JS; Hong JT; Jung JK; Han SB; Seo SY; Kim YH; Park SK; Kim HM; Lee K
    Phytother Res; 2014 Apr; 28(4):568-78. PubMed ID: 23824979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro metabolism of pyrethroid pesticides by rat and human hepatic microsomes and cytochrome p450 isoforms.
    Scollon EJ; Starr JM; Godin SJ; DeVito MJ; Hughes MF
    Drug Metab Dispos; 2009 Jan; 37(1):221-8. PubMed ID: 18948380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
    Nakamori F; Naritomi Y; Hosoya K; Moriguchi H; Tetsuka K; Furukawa T; Kadono K; Yamano K; Terashita S; Teramura T
    Drug Metab Dispos; 2012 Sep; 40(9):1771-7. PubMed ID: 22685216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolism of midazolam and comparison with other CYP enzyme substrates during intestinal absorption: in vitro studies with rat everted gut sacs.
    Arellano C; Philibert C; Vachoux C; Woodley J; Houin G
    J Pharm Pharm Sci; 2007; 10(1):26-36. PubMed ID: 17498391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ketoconazole on the intestinal metabolism, transport and oral bioavailability of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor and a P450 3A, P-glycoprotein dual substrate, in male Sprague-Dawley rats.
    Zhang Y; Hsieh Y; Izumi T; Lin ET; Benet LZ
    J Pharmacol Exp Ther; 1998 Oct; 287(1):246-52. PubMed ID: 9765344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics, disposition and lipid-modulating activity of 5-{2-[4-(3,4-difluorophenoxy)-phenyl]-ethylsulfamoyl}-2-methyl-benzoic acid, a potent and subtype-selective peroxisome proliferator-activated receptor alpha agonist in preclinical species and human.
    Frederick KS; Maurer TS; Kalgutkar AS; Royer LJ; Francone OL; Winter SM; Terra SG; Chen D; Gao X
    Xenobiotica; 2009 Oct; 39(10):766-81. PubMed ID: 19622022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters.
    Buckpitt A; Chang AM; Weir A; Van Winkle L; Duan X; Philpot R; Plopper C
    Mol Pharmacol; 1995 Jan; 47(1):74-81. PubMed ID: 7838135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Method for predicting human intestinal first-pass metabolism of UGT substrate compounds.
    Furukawa T; Yamano K; Naritomi Y; Tanaka K; Terashita S; Teramura T
    Xenobiotica; 2012 Oct; 42(10):980-8. PubMed ID: 22540538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical characterization of intestinal absorption and metabolism of promising anti-Alzheimer's dimer bis(7)-tacrine.
    Zhang L; Yu H; Li WM; Cheung MC; Pang YP; Gu ZM; Chan K; Wang YT; Zuo Z; Han YF
    Int J Pharm; 2008 Jun; 357(1-2):85-94. PubMed ID: 18358649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Species- and disposition model-dependent metabolism of raloxifene in gut and liver: role of UGT1A10.
    Jeong EJ; Liu Y; Lin H; Hu M
    Drug Metab Dispos; 2005 Jun; 33(6):785-94. PubMed ID: 15769887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo disposition and metabolism by liver and enterocyte microsomes of the antitubercular drug rifabutin in rats.
    Koudriakova T; Iatsimirskaia E; Tulebaev S; Spetie D; Utkin I; Mullet D; Thompson T; Vouros P; Gerber N
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1300-9. PubMed ID: 8968354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.
    Paine MF; Khalighi M; Fisher JM; Shen DD; Kunze KL; Marsh CL; Perkins JD; Thummel KE
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1552-62. PubMed ID: 9400033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.